# Ernexa Therapeutics Inc.: Form 8-K, filed Dec 17, 2018

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2018-12-17
- Accepted by EDGAR: Dec 17, 2018, 08:30 ET
- Period: 2018-12-14
- Accession: 0001493152-18-017572
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000149315218017572/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000149315218017572/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000149315218017572/form8-k.htm

Filed Dec 17, 2018.
Source: SEC EDGAR, the filing index for accession 0001493152-18-017572. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.